T2 Biosystms Correlations

TTOO Stock

USD 0.35 0.02 4.94%

The current 90-days correlation between T2 Biosystms and Genetic Technologies is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as T2 Biosystms moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if T2 Biosystms moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

T2 Biosystms Correlation With Market

Significant diversification

The correlation between T2 Biosystms and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding T2 Biosystms and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

Moving together with TTOO Stock

0.8	VALN	Valneva SE ADR Upward Rally	Pair Corr
0.73	ERNA	Eterna Therapeutics	Pair Corr
0.82	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.87	LLY	Eli Lilly	Pair Corr
0.95	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.88	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.63	IMAB	I Mab	Pair Corr
0.78	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.87	MRVI	Maravai Lifesciences	Pair Corr
0.82	NUVL	Nuvalent	Pair Corr
0.98	REGN	Regeneron Pharmaceuticals	Pair Corr
0.63	ABBV	AbbVie Inc	Pair Corr
0.94	AKAN	Akanda Corp	Pair Corr
0.8	AMGN	Amgen Inc	Pair Corr
0.86	ANRO	Alto Neuroscience,	Pair Corr
0.65	APGE	Apogee Therapeutics,	Pair Corr
0.75	ARDX	Ardelyx	Pair Corr
0.66	SMMT	Summit Therapeutics PLC Buyout Trend	Pair Corr

Moving against TTOO Stock

0.89	BMY	Bristol Myers Squibb	Pair Corr
0.87	GILD	Gilead Sciences	Pair Corr
0.69	ESPR	Esperion Therapeutics	Pair Corr
0.61	DYAI	Dyadic International	Pair Corr
0.79	MNMD	Mind Medicine	Pair Corr
0.68	ABCL	Abcellera Biologics	Pair Corr
0.53	MOLN	Molecular Partners	Pair Corr
0.96	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	BIOC	GENE	HTGM	INBS	IDXG	BIAF	SQL	TMO	ILMN
BIOC		0.02	0.88	0.48	-0.23	0.9	-0.01	0.93	-0.48	BIOC
GENE	0.02		0.01	0.47	0.0	-0.01	0.14	-0.02	-0.31	GENE
HTGM	0.88	0.01		0.27	0.14	0.85	0.27	0.92	-0.33	HTGM
INBS	0.48	0.47	0.27		-0.42	0.32	0.02	0.4	-0.35	INBS
IDXG	-0.23	0.0	0.14	-0.42		-0.21	0.35	-0.06	0.35	IDXG
BIAF	0.9	-0.01	0.85	0.32	-0.21		-0.02	0.89	-0.43	BIAF
SQL	-0.01	0.14	0.27	0.02	0.35	-0.02		0.09	-0.03	SQL
TMO	0.93	-0.02	0.92	0.4	-0.06	0.89	0.09		-0.26	TMO
ILMN	-0.48	-0.31	-0.33	-0.35	0.35	-0.43	-0.03	-0.26		ILMN
	BIOC	GENE	HTGM	INBS	IDXG	BIAF	SQL	TMO	ILMN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TMO	+ 0.93	BIOC
TMO	+ 0.92	HTGM
BIAF	+ 0.9	BIOC
TMO	+ 0.89	BIAF
HTGM	+ 0.88	BIOC
BIAF	+ 0.85	HTGM

High negative correlations

ILMN	- 0.48	BIOC
ILMN	- 0.43	BIAF
IDXG	- 0.42	INBS
ILMN	- 0.35	INBS
ILMN	- 0.33	HTGM
ILMN	- 0.31	GENE

Risk-Adjusted Indicators

There is a big difference between TTOO Stock performing well and T2 Biosystms Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze T2 Biosystms' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BIOC	6.16	(2.52)	0.00	(2.47)	0.00	0.00	9.24	(15.27)	66.54
GENE	0.56	(0.10)	0.00	4.25	0.00	0.00	1.37	(2.44)	7.76
HTGM	9.08	(1.60)	0.00	6.65	0.00	0.00	25.00	(20.00)	65.45
INBS	4.79	(0.86)	0.00	(0.51)	0.00	0.00	9.93	(10.59)	25.53
IDXG	10.38	2.71	0.21	6.71	9.49	(14.08)	18.81	(16.19)	194.90
BIAF	4.27	(0.42)	0.00	2.34	0.00	0.00	10.44	(8.25)	47.52
SQL	4.56	0.10	0.01	(0.29)	4.49	(8.97)	12.50	(10.64)	50.87
TMO	0.98	(0.27)	0.00	(0.43)	0.00	0.00	1.66	(2.30)	7.00
ILMN	1.86	0.03	0.01	0.05	2.14	(2.11)	4.03	(3.13)	14.14

T2 Biosystms Corporate Management

Roger Smith	Senior Development	Profile
Aparna MD	Chief Board	Profile
Kelley Morgan	Chief Officer	Profile
Michael Esq	Sr Counsel	Profile
Brett Giffin	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC